LUP Statistics
Record
- Title
- Are Sulfonylureas Less Desirable Than DPP-4 Inhibitors as Add-on to Metformin in the Treatment of Type 2 Diabetes?
- Type
- Journal Article
- Publ. year
- 2011
- Author/s
- Ahrén, Bo
- Department/s
- Medicine, Lund; EXODIAB: Excellence of Diabetes Research in Sweden
- In LUP since
- 2016-04-04
Downloads
| Total | This Year | This Month |
| 638 | 5 | 1 |
United States of America  |
253 (40%) |
India  |
73 (11%) |
China  |
55 (9%) |
Germany  |
20 (3%) |
United Kingdom of Great Britain and Northern Ireland  |
19 (3%) |
Japan  |
14 (2%) |
Sweden  |
13 (2%) |
Singapore  |
10 (2%) |
Egypt  |
10 (2%) |
Hong Kong (China)  |
9 (1%) |
Spain  |
9 (1%) |
Australia  |
8 (1%) |
European Union location  |
8 (1%) |
France  |
7 (1%) |
Bangladesh  |
7 (1%) |
South Korea  |
7 (1%) |
Brazil  |
7 (1%) |
Indonesia  |
6 (1%) |
Taiwan (China)  |
5 (1%) |
Philippines  |
5 (1%) |
Pakistan  |
5 (1%) |
Thailand  |
5 (1%) |
South Africa  |
4 (1%) |
Italy  |
4 (1%) |
Turkiye  |
4 (1%) |
Portugal  |
4 (1%) |
Russian Federation  |
3 (0%) |
Hungary  |
3 (0%) |
Malaysia  |
3 (0%) |
Lithuania  |
3 (0%) |
Argentina  |
3 (0%) |
Bolivia  |
2 (0%) |
Ireland  |
2 (0%) |
Asia-Pacific location  |
2 (0%) |
Saudi Arabia  |
2 (0%) |
Switzerland  |
2 (0%) |
Syrian Arab Republic  |
2 (0%) |
Jordan  |
2 (0%) |
Canada  |
2 (0%) |
Mexico  |
2 (0%) |
Iraq  |
2 (0%) |
Qatar  |
2 (0%) |
Nigeria  |
2 (0%) |
Tunisia  |
2 (0%) |
Unknown  |
2 (0%) |
Denmark  |
2 (0%) |
Finland  |
2 (0%) |
Greece  |
2 (0%) |
Unknown (Satellite Provider)  |
1 (0%) |
Malta  |
1 (0%) |
Belgium  |
1 (0%) |
Senegal  |
1 (0%) |
Viet Nam  |
1 (0%) |
Armenia  |
1 (0%) |
Peru  |
1 (0%) |
Netherlands (Kingdom of the)  |
1 (0%) |
Ukraine  |
1 (0%) |
Poland  |
1 (0%) |
Kuwait  |
1 (0%) |
Iran  |
1 (0%) |
Israel  |
1 (0%) |
Honduras  |
1 (0%) |
Algeria  |
1 (0%) |
Kenya  |
1 (0%) |
Venezuela  |
1 (0%) |
Belarus  |
1 (0%) |